Tevogen Inc. (TVGNW) revenue by segment

TVGNWNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as TVGN

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 4/30

$0.08−0.01 (-10.51%)

Close on Nov 2, 2026Market cap $36.40MP/E –Yield –

Tevogen Inc. revenue by segment

Tevogen does not break out revenue by segment, region or product in the tagged data of its filings for this period type.